Veeva (VEEV) Systems and OpenEvidence announced the formation of a long-term partnership to jointly create and market Open Vista. Open Vista will use AI to increase patient access to clinical trials, accelerate drug discovery through better understanding of unmet needs, and improve understanding and adoption of existing approved medicines to provide better patient outcomes. The first Open Vista product offerings are expected to be released in 2026.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Veeva says AI Agents planned for commercial availability starting December
- CoreWeave, Sunrun, NuScale, Veeva, Analog Devices: Insider Moves Unveiled!
- Netflix, Veeva, AST SpaceMobile, Alphabet, Agilent: Trending by Analysts
- Netflix upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
- Veeva Systems Poised for Growth: Buy Rating Affirmed Amid CRM Success and Industry Trends